Associate Professor, Pathology, USC School of Medicine
Pediatric Endocrinology
Dr. Hiroyuki Shimada, MD
|
|
Give Review
Hiroyuki Shimada is an expert in the field of Pediatric Endocrinology. He received awards:"Whos Who in Medicine and Healthcare". Hiroyuki Shimada is a published MD. He has 20 publications published. The most current publication "Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index (MKI) in Neuroblastoma: A Report from the Children's Oncology Group."
Publications
- Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index (MKI) in Neuroblastoma: A Report from the Children's Oncology Group.
- MYCN-dependent Expression of Sulfatase-2 Regulates Neuroblastoma Cell Survival.
- Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
- Neuroblastoma or not neuroblastoma.
- Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter⢠system.
- Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.
- Critical Role of STAT3 in IL-6-Mediated Drug Resistance in Human Neuroblastoma.
- Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Onco...
- Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches t...
- Management of Stage 4S Composite Neuroblastoma With a MYCN-amplified Nodule.
- Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.
- Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
- Forearm skeletal muscle neuroblastoma in a child: a rare primary location.
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma.
- Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
- Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.
- The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
- Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncol...
- Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
Doctors Specialties
- Pediatric Pathology
- Pediatric Endocrinology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Hospital
-
Children's Hospital Los Angeles
Helpful Reviews
Similar Doctors
|
|
Dr. Amy M. Vedin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phuong T. Hoang, MD |
|
|
Dr. Richard A. Fefferman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danielle L. Borut, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Solomon A. Kaplan, MD |
|
|
Dr. Benjamin H. Landing, MD |
|
|
Dr. Masoud Shamszadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nick M. Shillingford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Galen M. Schauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Teitell, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shengmei Zhou, MD |
|
|
Dr. Anna Pawlikowska Haddal, MD |
|
|
Dr. Debra D. Jeandron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manal Habib, MD |
|
|
Dr. Leslie Kimura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moneil M. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Parham III, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|